tiprankstipranks
Advertisement
Advertisement
InspireMD initiates voluntary U.S. recall of CGuard Prime 135 cm system
PremiumThe FlyInspireMD initiates voluntary U.S. recall of CGuard Prime 135 cm system
27d ago
InspireMD Recalls CGuard Prime Delivery System, Pauses U.S. Launch
Premium
Company Announcements
InspireMD Recalls CGuard Prime Delivery System, Pauses U.S. Launch
29d ago
InspireMD announces FDA approval of IDE application for CGUARDIANS III study
Premium
The Fly
InspireMD announces FDA approval of IDE application for CGUARDIANS III study
29d ago
InspireMD Reports Strong Q4 2025 Growth and Expansion
PremiumCompany AnnouncementsInspireMD Reports Strong Q4 2025 Growth and Expansion
2M ago
InspireMD reports Q4 EPS (14c), consensus (19c)
Premium
The Fly
InspireMD reports Q4 EPS (14c), consensus (19c)
2M ago
InspireMD sees FY26 revenue $13M-$15M, consensus $14.55M
Premium
The Fly
InspireMD sees FY26 revenue $13M-$15M, consensus $14.55M
2M ago
InspireMD reports inducement grants under Nasdaq listing rule
PremiumThe FlyInspireMD reports inducement grants under Nasdaq listing rule
4M ago
InspireMD announces publication of C-GUARDIANS trial
Premium
The Fly
InspireMD announces publication of C-GUARDIANS trial
5M ago
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer?
Premium
Company Announcements
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100